During the past decade, UMHAT Dr Georgi Stranski; Hematology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UMHAT Dr Georgi Stranski; Hematology" #1 collaborator was "APCER Life Sciences" with 1 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "KCAS Bio" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "UMHAT Dr Georgi Stranski; Hematology" are "Non-Hodgkin's Lymphoma" (3 trials), "Alzheimer's Disease" (1 trials), "Arthritis, Rheumatoid" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials) and "Smoking Cessation" (1 trials). Many other conditions were trialed in "UMHAT Dr Georgi Stranski; Hematology" in a lesser frequency.

Most popular intervention types in "UMHAT Dr Georgi Stranski; Hematology" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ALZT-OP1a" (1 trials), "ALZT-OP1b" (1 trials), "Chemotherapy (Induction Period)" (1 trials), "Chlorambucil" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "UMHAT Dr Georgi Stranski; Hematology" are 7 trials for "All" genders.

Currently, there are NaN active trials in "UMHAT Dr Georgi Stranski; Hematology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in UMHAT Dr Georgi Stranski; Hematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UMHAT Dr Georgi Stranski; Hematology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".